TGA - Australian Market Opens Up To Clever Leaves With GMP Certification For Cannabis Manufacturing | Benzinga
Clever Leaves Holdings Inc. (NASDAQ:CLVR), has been granted Australian GMP certification for its facilities in Colombia by the Therapeutic Goods Administration (TGA).
The certification authorizes Clever Leaves to manufacture cannabis products for medical marijuana patients in Australia, the Colombia-based company announced on Wednesday.
The Australian GMP certification from the TGA safeguards against product contamination, variations in compound concentrations, mix-ups, incorrect labeling and other potential issues. The certification is a prerequisite for the manufacturing and commercialization of cannabis products in the Australian market.
See also: Meet The First Vertically Integrated Medicinal Cannabis Company Certified As Carbon-Neutral
“The awarding of Australian-GMP certification signifies a major milestone for Clever Leaves by further highlighting our commitment to producing high-quality and safe cannabis products ...